Search research articles
Contact Us
Filters
Showing results (141-150 of 152) with videos related to
Page
of 16
Sort By:
ESC Heart Failure
|
October 28, 2018
Cardiac expression of neutrophil gelatinase-associated lipocalin in a model of cancer cachexia-induced cardiomyopathy
Vincenzo Musolino, Sandra Palus, Celine Latouche, et al.
International Journal of Cardiology
|
December 31, 2010
Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure
Anja Sandek, Ingvar Bjarnason, Hans-Dieter Volk, et al.
International Journal of Cardiology
|
January 31, 2013
TWIST1 regulates the activity of ubiquitin proteasome system via the miR-199/214 cluster in human end-stage dilated cardiomyopathy
Anna Baumgarten, Claudia Bang, Anika Tschirner, et al.
Nutrition & Metabolism
|
August 23, 2012
Theophylline is able to partially revert cachexia in tumour-bearing rats
Mireia Olivan, Jochen Springer, Sílvia Busquets, et al.
International Journal of Cardiology
|
December 27, 2015
The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure
Nicole Ebner, Ewa A Jankowska, Piotr Ponikowski, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
July 19, 2019
Macrophages protect against loss of adipose tissue during cancer cachexia
Merve Erdem, Diana Möckel, Sandra Jumpertz, et al.
Free Radical Biology & Medicine
|
July 21, 2007
Substance P released by TRPV1-expressing neurons produces reactive oxygen species that mediate ethanol-induced gastric injury
David Gazzieri, Marcello Trevisani, Jochen Springer, et al.
Journal of the American College of Cardiology
|
February 4, 2012
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial
Stephan von Haehling, Joerg C Schefold, Ewa A Jankowska, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
November 8, 2022
The atypical β-blocker S-oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model
Luping Yuan, Jochen Springer, Sandra Palus, et al.
European Heart Journal
|
August 31, 2013
Prevention of liver cancer cachexia-induced cardiac wasting and heart failure
Jochen Springer, Anika Tschirner, Arash Haghikia, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 152) with videos related to
Sort By:
Page
of 16
ESC Heart Failure
|
October 28, 2018
Cardiac expression of neutrophil gelatinase-associated lipocalin in a model of cancer cachexia-induced cardiomyopathy
Vincenzo Musolino, Sandra Palus, Celine Latouche, et al.
International Journal of Cardiology
|
December 31, 2010
Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure
Anja Sandek, Ingvar Bjarnason, Hans-Dieter Volk, et al.
International Journal of Cardiology
|
January 31, 2013
TWIST1 regulates the activity of ubiquitin proteasome system via the miR-199/214 cluster in human end-stage dilated cardiomyopathy
Anna Baumgarten, Claudia Bang, Anika Tschirner, et al.
Nutrition & Metabolism
|
August 23, 2012
Theophylline is able to partially revert cachexia in tumour-bearing rats
Mireia Olivan, Jochen Springer, Sílvia Busquets, et al.
International Journal of Cardiology
|
December 27, 2015
The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure
Nicole Ebner, Ewa A Jankowska, Piotr Ponikowski, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
July 19, 2019
Macrophages protect against loss of adipose tissue during cancer cachexia
Merve Erdem, Diana Möckel, Sandra Jumpertz, et al.
Free Radical Biology & Medicine
|
July 21, 2007
Substance P released by TRPV1-expressing neurons produces reactive oxygen species that mediate ethanol-induced gastric injury
David Gazzieri, Marcello Trevisani, Jochen Springer, et al.
Journal of the American College of Cardiology
|
February 4, 2012
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial
Stephan von Haehling, Joerg C Schefold, Ewa A Jankowska, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
November 8, 2022
The atypical β-blocker S-oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model
Luping Yuan, Jochen Springer, Sandra Palus, et al.
European Heart Journal
|
August 31, 2013
Prevention of liver cancer cachexia-induced cardiac wasting and heart failure
Jochen Springer, Anika Tschirner, Arash Haghikia, et al.
Page
of 16